EMILEE HARVEY: Open Payments
NPI 1700439015 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,759 in 366 payments from 25 companies in 2025. Trend: 2023 $2,554 · 2024 $6,008 · 2025 $5,759
Food & beverage: $5,643Education: $115
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 173 | $1,867 |
| ABBVIE INC. | 32 | $869 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 36 | $422 |
| Lilly USA, LLC | 21 | $392 |
| PFIZER INC. | 28 | $377 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $281 |
| Phathom Pharmaceuticals, Inc. | 6 | $254 |
| Novo Nordisk Inc | 5 | $183 |
| Madrigal Pharmaceuticals | 4 | $181 |
| GENZYME CORPORATION | 6 | $169 |
Products named: TREMFYA, SKYRIZI, VELSIPITY, OMVOH, LINZESS, VOQUEZNA, XIFAXAN, Wegovy.
Industry payments across NY — which companies pay providers there.
